Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis.
暂无分享,去创建一个
A. Mustafa | U. Chaturvedi | A S Mustafa | U C Chaturvedi | R Agarwal | E A Elbishbishi | E. A. Elbishbishi | R. Agarwal
[1] D. Ha,et al. Tumor necrosis factor alpha levels in plasma and whole‐blood culture in dengue‐infected patients: Relationship between virus detection and pre‐existing specific antibodies , 1998, Journal of medical virology.
[2] M. Sinniah,et al. Augmented inflammatory cytokines in primary dengue infection progressing to shock. , 1995, Singapore medical journal.
[3] B. Dewald,et al. Monocyte chemoattractant protein 1 and interleukin 8 production by rheumatoid synoviocytes. Effects of anti-rheumatic drugs. , 1994, Cytokine.
[4] A. Sampieri,et al. Analysis of the local kinetics and localization of interleukin‐1α, tumour necrosis‘qc factor‐α and transforming growth factor‐β, during the course of experimental pulmonary tuberculosis , 1997 .
[5] A. Pacsa,et al. Role of interleukin-12 in patients with dengue hemorrhagic fever. , 2000, FEMS immunology and medical microbiology.
[6] U. Chaturvedi,et al. Effect of dengue virus infection on Fc-receptor functions of mouse macrophages. , 1983, The Journal of general virology.
[7] T. Vitarana,et al. Elevated tumour necrosis factor in dengue fever and dengue haemorrhagic fever. , 1991, The Ceylon medical journal.
[8] T. Mosmann,et al. The expanding universe of T-cell subsets: Th1, Th2 and more. , 1996, Immunology today.
[9] A. Nisalak,et al. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. , 1991, The Journal of clinical investigation.
[10] S. Kapoor,et al. A clinical study of the patients with dengue hemorrhagic fever during the epidemic of 1996 at Lucknow, India. , 1999, The Southeast Asian journal of tropical medicine and public health.
[11] R. Dhawan,et al. Breakdown of the blood-brain barrier during dengue virus infection of mice. , 1991, The Journal of general virology.
[12] M. Sinniah,et al. Dengue haemorrhagic fever and dengue shock syndrome: are they tumour necrosis factor-mediated disorders? , 1991, FEMS microbiology immunology.
[13] S. Kapoor,et al. SHIFT FROM A TH1-TYPE RESPONSE TO TH2-TYPE IN DENGUE HAEMORRHAGIC FEVER , 1999 .
[14] P. Puccetti,et al. Interleukin-12 in infectious diseases , 1997, Clinical microbiology reviews.
[15] A. Pacsa,et al. Sequential production of cytokines by dengue virus‐infected human peripheral blood leukocyte cultures , 1999, Journal of medical virology.
[16] B. Seliger,et al. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. , 1998, Journal of immunology.
[17] M. Sharma,et al. Increased capillary permeability mediated by a dengue virus-induced lymphokine. , 1990, Immunology.
[18] S. Lam,et al. Dengue haemorrhagic fever , 1995 .
[19] Duane J. Gubler,et al. Dengue and Dengue Hemorrhagic Fever , 1998, Clinical Microbiology Reviews.
[20] U. Chaturvedi,et al. Production of nitrite by dengue virus‐induced cytotoxic factor , 1996, Clinical and experimental immunology.
[21] A. Nisalak,et al. Elevated plasma interleukin‐10 levels in acute dengue correlate with disease severity , 1999, Journal of medical virology.
[22] D. Hober,et al. Serum Levels of Tumor Necrosis Factor-α (TNF-α), Interleukin-6 (IL-6), and Interleukin-1β (IL-1β) in Dengue-Infected Patients , 1993 .
[23] Y. S. Lin,et al. Immunopathogenesis of dengue virus infection. , 2001, Journal of biomedical science.
[24] Chaturvedi,et al. Profile of transforming growth factor‐beta 1 in patients with dengue haemorrhagic fever , 1999, International journal of experimental pathology.
[25] S. Kapoor,et al. Elevated levels of IL‐8 in dengue hemorrhagic fever , 1998, Journal of medical virology.
[26] U. Chaturvedi,et al. Respiratory Burst by Dengue-Virus-Induced Cytotoxic Factor , 1998, Medical Principles and Practice.
[27] V. Strand,et al. Combination biologic therapy. , 1999, Clinical and experimental rheumatology.
[28] E. Chungue,et al. Plasma levels of tumour necrosis factor a and transforming growth factor β-1 in children with dengue 2 virus infection in French Polynesia , 1998 .
[29] Active immunization by a dengue virus‐induced cytokine , 1994, Clinical and experimental immunology.
[30] S. A. Oliveira,et al. Increased pro-inflammatory cytokines (TNF-alpha and IL-6) and anti-inflammatory compounds (sTNFRp55 and sTNFRp75) in Brazilian patients during exanthematic dengue fever. , 1999, Memorias do Instituto Oswaldo Cruz.
[31] U. Chaturvedi,et al. Obligatory role of macrophages in dengue virus antigen presentation to B lymphocytes. , 1989, Immunology.
[32] D. Ireland,et al. IL-12 and Viral Infections , 1998, Cytokine & Growth Factor Reviews.
[33] D. Kwiatkowski,et al. Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. , 1998, The Journal of infectious diseases.
[34] H. Young,et al. IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. , 1999, Journal of immunology.
[35] N. Horwood,et al. Interleukin-18: perspectives on the newest interleukin. , 1998, Cytokine & growth factor reviews.